- Global authority in hyperspecialized nerve, muscle, and whole-body reconstruction
- Procedures so rare only a handful of surgeons worldwide can perform them
- Previously spending $1.5M+ annually on paid advertising with zero compounding equity
- Less specialized providers were outranking IFAR in search results despite inferior clinical credentials
- Transformed to SEO-first model where organic now outperforms paid as primary growth driver
World-Class Surgeons. Invisible Online.
The Institute for Advanced Reconstruction (IFAR) is the global authority in hyperspecialized nerve, muscle, and whole-body reconstruction — procedures so rare that only a handful of surgeons worldwide can perform them. Patients travel from across the U.S. and around the world for a chance to reclaim their lives.
Growth was bought, not built. The business relied heavily on paid advertising — over $1.5M annually — to generate leads. But this spend was transactional: pause the budget, and the demand pipeline collapsed. There was no owned acquisition channel, no compounding SEO equity, and no scalable, defensible growth engine.
“We had the skill, the cases, and the outcomes to change lives — but we were invisible to the people who needed us most. It wasn’t just a marketing problem. It was a missed chance to save patients’ futures.”
Dr. Andrew Elkwood, Founder, The Institute for Advanced Reconstruction
A Rare Clinical Asset Trapped by a Paid-Only Model.
A rare, high-margin asset held back by a go-to-market engine that couldn’t support enterprise-level expansion. IFAR’s hyperspecialized surgical expertise was perfectly positioned for global demand capture and scalable growth. But the go-to-market engine couldn’t support enterprise-level expansion.
Building an SEO-First Growth Engine.
We rebuilt IFAR’s digital presence into a fully integrated acquisition platform where every channel compounds and every click drives measurable enterprise value.
We repositioned IFAR from regional to global. National and global SEO expansion ranking for high-value reconstructive terms in target markets worldwide. Hub-and-spoke content architecture with comprehensive coverage of symptom, condition, and treatment searches. Authority content engine converting searchers into booked consults.
We re-engineered the site to turn visits into booked consultations. Patient-centric navigation streamlining journey from search to scheduling. Procedure-specific landing pages for niche surgeries. HIPAA-compliant forms and scheduling with minimal friction.
Paid became an amplifier for organic dominance, not a crutch. SEO-informed PPC targeting aligned with proven high-value keywords. Conversion-optimized landing pages for every ad click. ROI-based budget allocation shifted spend toward profit-driving procedures.
Real-time insight now fuels real-time action. Real-time dashboards for immediate visibility into lead sources, conversion paths, and ROI. Dynamic budget reallocation flowing capital from underperformers to top drivers. Cross-channel optimization tuning SEO, PPC, and UX together for compounding returns.
Increase in monthly organic sessions, establishing global search authority.
Search footprint expanded 8x — ranking keywords up from 4,200 to 33,600, commanding space across every high-intent procedure search.
Lift in non-branded traffic, reaching entirely new patient audiences worldwide.
Six Months to Global Search Leadership.
Organic now drives the majority of qualified patient acquisition — at lower cost and higher conversion rates than ever before. IFAR transitioned from a paid-heavy, regionally known practice to a global leader dominating search for its highest-value procedures.
| Metric | Before | After | Change | Why It Matters |
|---|---|---|---|---|
| Customer Acquisition Cost (CAC) | $2,840 | $1,647 | ↓ 42% | Lower acquisition cost increases EBITDA margins and scalability. |
| Cost per High-Value Case (>$20,000) | $4,200 | $2,520 | ↓ 40% | More efficient acquisition of the most profitable procedures. |
| % Revenue from Owned Channels | 22% | 61% | ↑ 39 pts | Builds a defensible growth engine not dependent on paid. |
| Share of Search (Top 25 Procedures) | 8% | 34% | ↑ 26 pts | Market dominance in high-intent searches drives patient flow. |
| Geographic Reach | 3 states | 7 states + intl. | ↑ 133% | Expands addressable market without adding physical locations. |
| Consult-to-Surgery Conversion Rate | 31% | 47% | ↑ 16 pts | Optimized UX and targeting improves operational efficiency. |
| Average Patient Value (APV) | $18,400 | $24,700 | ↑ 34% | Captures downstream revenue from additional/revision procedures. |
- Surge in high-ticket procedures (microsurgical reconstructions, full-body lifts)
- Underperforming locations saw inquiry spikes within 90 days
- Organic now outperforms paid as the primary growth driver
- $1.5M/yr paid ad dependency
- 22% owned channels only
- 4,200 keywords ranked
- 3 states only, no international
- -42% CAC ($2,840 → $1,647)
- 61% owned channel revenue
- 33,600 keywords ranked
- 7 states + international reach
A Permanent Shift in Unit Economics.
By shifting IFAR from a spend-dependent model to an asset-based, compounding demand generation platform, we achieved measurable enterprise value creation.
Improving margins and freeing capital for reinvestment in expansion and talent.
By capturing and converting higher-margin, complex cases that drive outsized profitability.
From 3 states to 7 states plus international — without adding physical locations.
Through organic dominance in high-intent procedure searches, reducing reliance on rented traffic.
Supporting platform scalability and higher EBITDA multiples at exit.
Revenue from owned channels surged from 22% to 61% — this isn’t a one-time campaign lift — it’s a permanent shift in the unit economics of patient acquisition.